In AD, while CSF t-tau reflects amyloid-dependent neurodegeneration or increased tau secretion from amyloid-affected neurons, CSF NfL is considered a measure of both amyloid-dependent and independent neuronal loss [92]. Here, MAPT is linked to Alzheimer disease.